This is not the most recent version of the article. View current version (27 MAR 2014)

Intervention Protocol

Pharmacological interventions for schizoid personality disorder

  1. Saeed Farooq2,
  2. Birgit A Völlm3,
  3. Jutta Stoffers4,
  4. Simon Gibbon5,
  5. Conor Duggan3,
  6. Michael Ferriter1,*,
  7. Jane A Dennis6,
  8. Klaus Lieb7

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 16 MAR 2011

DOI: 10.1002/14651858.CD009048


How to Cite

Farooq S, Völlm BA, Stoffers J, Gibbon S, Duggan C, Ferriter M, Dennis JA, Lieb K. Pharmacological interventions for schizoid personality disorder (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No.: CD009048. DOI: 10.1002/14651858.CD009048.

Author Information

  1. 1

    Nottinghamshire Healthcare NHS Trust, Literature and Evidence Research Unit (LERU), Institute of Mental Health, Woodbeck, Nottinghamshire, UK

  2. 2

    Kyber Medical University, Postgraduate Medical Institute, Peshawar, Pakistan

  3. 3

    Institute of Mental Health, Section of Forensic Mental Health, Nottingham, UK

  4. 4

    & Department of Psychiatry and Psychotherapy, Department of Psychiatry and Psychotherapy, Freiburg, Mainz, Germany

  5. 5

    St Andrew's Healthcare, Northampton, UK

  6. 6

    Queen's University, c/o Developmental, Psychosocial and Learning Problems Group, Belfast, UK

  7. 7

    University Medical Center Mainz, Department of Psychiatry and Psychotherapy, Mainz, Germany

*Michael Ferriter, Literature and Evidence Research Unit (LERU), Institute of Mental Health, Nottinghamshire Healthcare NHS Trust, The Clair Chilvers Centre, Rampton Hospital, Woodbeck, Nottinghamshire, DN22 0PD, UK. Michael.Ferriter@nottshc.nhs.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 16 MAR 2011

SEARCH

This is not the most recent version of the article. View current version (27 MAR 2014)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the effects of pharmacological interventions for people with schizoid personality disorder (SPD).